İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2022 · article

Assessment of auditory functions in patients with hepatic glycogen storage diseases

ISSN0041-4301
YÖKSİS OpenAlex Açık erişim · diamond TR Index
Yıl2022
Atıf3OpenAlex
Yüzdelik%63,2
FWCI0,481,00 = dünya ortalaması
Scopus (SJR)Q3
WoS (JCR)Q4

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıThe Turkish Journal of Pediatrics
  • Katalog eşleşmesi (ISSN)Turkish Journal of Pediatrics
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

BACKGROUND: Hepatic glycogen storage diseases are a group of diseases manifesting mainly with hypoglycemia and hepatomegaly. The patients require frequent daytime and nocturnal feedings. Hypoglycemia may cause sensorineural hearing loss and nocturnal feeding is a risk factor for the development of gastroesophageal reflux that may cause chronic otitis media and hearing loss consequently. We aimed to determine the prevalence and characteristics of hearing loss in hepatic glycogen storage diseases. METHODS: A total of 24 patients with hepatic glycogen storage disease (15 glycogen storage disease type I and 9 non type I) and 24 age/sex matched healthy controls were enrolled in the study. Pure tone audiometer, immitansmetry, acoustic reflex measurement, otoacoustic emission test (OAE) and auditory brainstem response (ABR) tests were applied to all participants. RESULTS: Hearing loss was determined in 17/24 patients (12 glycogen storage disease type I and 5 non type I) with pure tone audiometer. Interpretation of all the findings revealed a total of 8 patients had conductive and 9 had mixed hearing loss. All parameters were significantly different than the control group. CONCLUSIONS: This is the first study to comprehensively assess the auditory functions of patients with hepatic glycogen storage disease. Audiological findings determined a significantly increased prevalence of conductive/ mixed type hearing loss in the patient group which is a new finding in the literature. Further studies with extended patient numbers are required to enlighten the underlying pathophysiology.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

3atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 1 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2025 NOD-m: a novel clinical score for predicting hearing loss in inherited metabolic disorders.Atıf 0 · OpenAlex

Yazarlar

10
  1. MERVE EMECAN ŞANLI 1
  2. NURİYE YILDIRIM GÖKAY 2
  3. HAKAN TUTAR 3
  4. BÜLENT GÜNDÜZ 4
  5. Ekin Özsaydı 5
  6. AYŞE KILIÇ 6
  7. ASLI İNCİ 7
  8. İLYAS OKUR 8
  9. FATİH SÜHEYL EZGÜ 9
  10. LEYLA TÜMER GAZİ ÜNİVERSİTESİ 10